U-M Health again earns nursing’s highest honor through Magnet redesignation
ANN ARBOR, Mich. – University of Michigan Health nurses continue to be recognized as among the best in the nation, again receiving the highest honor in nursing.
News
Common prostate cancer medications may be less safe than previously thought
Men with advanced prostate cancer taking abiraterone or enzalutamide plus hormone therapy were at higher risk of serious medical issues than their peers undergoing hormone therapy alone.
‘My life matters’: resilience after traumatic spinal cord injury
Research shows what key factors affect flourishing after the injury.
How a social work researcher’s experience with young adult cancer informed his work
Bradley Zebrack reflects on the insights he’s applied from his cancer journey to his job.
The why of the silent X
Research unravels the mystery of how one of the X chromosomes in female embryonic stem cells is silenced
Peak performance: how climbing mountains transformed a surgeon
Reaching the tallest peaks has not just made the veteran physician a better surgeon, it’s made him a better person.
Aging well in a pandemic: Older adults share what it takes
Poll shows most people over 50 feel their health is the same or better than before 2020, but also reveals subgroups that may need more support to achieve healthy aging
How a wife recognized the signs of stroke and helped save her husband
A life-threatening stroke, followed by quick medical attention, led to Jack Jenkins’ remarkable recovery.
Hospices vary widely in prescribing “comfort kit” medications
Which hospice they enter, rather than their condition, may determine which patients receive antipsychotics or benzodiazepines to quell end-of-life symptoms.
Helping kids with congenital hand differences
A hand surgeon explains the importance of parents advocating for their child with hands that don’t look or function the same as others.
Early study finds new lymphoma drug effective
Eighty percent of patients with a subset of lymphoma saw their cancers shrink after taking zanubrutinib in a clinical trial.
